Changes in Right Ventricular Structure and Function Assessed Using Cardiac Magnetic Resonance Imaging in Bosentan-Treated Patients With Pulmonary Arterial Hypertension
Authors:
- Kelly M. ChinKCKelly M. Chin
- Martha KingmanMKMartha Kingman
- James A. de LemosJLJames A. de Lemos
- John J. WarnerJWJohn J. Warner
- Sharon ReimoldSRSharon Reimold
- Ron PeshockRPRon Peshock
- Fernando TorresFTFernando Torres
- 1 June 2008
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 101 (11) , 1669-1672
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertensionEuropean Heart Journal, 2007
- Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertensionEuropean Heart Journal, 2005
- Usefulness of B‐Type Natriuretic Peptide as a Predictor of Treatment Outcome in Pulmonary Arterial HypertensionCongestive Heart Failure, 2004
- Prognosis of Pulmonary Arterial Hypertension*Chest, 2004
- Clinical classification of pulmonary hypertensionJACC, 2004
- Long-term intravenous epoprostenol infusion in primary pulmonary hypertensionJACC, 2002
- Echocardiographic predictors of adverse outcomes in primary pulmonary hypertensionJACC, 2002
- Evaluation of Right Ventricular Performance With a Right Ventricular Ejection Fraction Thermodilution Catheter and MRI in Patients With Pulmonary HypertensionChest, 2001
- Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary HypertensionCirculation, 2000
- Normal Human Right and Left Ventricular Mass, Systolic Function, and Gender Differences by Cine Magnetic Resonance ImagingJournal of Cardiovascular Magnetic Resonance, 1999